(VIANEWS) – The NASDAQ ended the session with Royalty Pharma rising 5.41% to $42.44 on Thursday, after two sequential sessions in a row of losses. NASDAQ Composite rose 0.05% to $14,942.83, after three successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Today’s last reported volume for Royalty Pharma is 5830750, 170.49% above its average volume of 2155620.
Royalty Pharma’s last close was $40.84, 23.28% below its 52-week high of $53.23.
Royalty Pharma’s Sales
Royalty Pharma’s sales growth is 12.1% for the present quarter and 6.2% for the next. The company’s growth estimates for the present quarter and the next is 41.7% and 171.4%, respectively.
Royalty Pharma’s Revenue
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.29B for the twelve trailing months.
Royalty Pharma’s Stock Yearly Top and Bottom Value
Royalty Pharma’s stock is valued at $42.44 at 16:18 EST, way under its 52-week high of $53.23 and way above its 52-week low of $34.86.
Royalty Pharma’s Moving Average
Royalty Pharma’s worth is higher than its 50-day moving average of $38.89 and higher than its 200-day moving average of $40.64.
More news about Royalty Pharma (RPRX).